Kastelein Johannes Jacob PieterDirector, CSO
Sell $1.1M of disclosed value in NewAmsterdam Pharma Company N.V. $NAMS.
Sell
GLP-1 & Metabolic Health
- Last updated
- Jul 20, 2026
- Based on
- 226 actions
- Gurus considered
- 148
- Stocks covered
- 170
Obesity, diabetes, GLP-1, and metabolic disease exposure. This page tracks 226 investor, Congress, and insider actions tied to GLP-1 & Metabolic Health within Healthcare Innovation, connecting the industry classification with the people and institutions currently showing activity. It gives context from 148 gurus across 170 stocks, so the feed can be read as an industry-level signal rather than a loose list of single-stock events.
GLP-1 & Metabolic Health Smart Money Notes
Turakhia MinangCHIEF MED / SCI OFCR EVP ADVTECH
Sell $1.1M of disclosed value in iRhythm Technologies, Inc. $IRTC.
Sell
McEvoy AshleyDirector, President, CEO
Buy $1.0M of disclosed value in Insulet Corporation - Common Stock $PODD.
Buy
Patterson ChadCHIEF COMM, PRODUCT OFFICER
Sell $1.2M of disclosed value in iRhythm Technologies, Inc. $IRTC.
Sell
Collins Helen LouiseCMO
Sell $1.2M of disclosed value in Enliven Therapeutics, Inc. $ELVN.
Sell
Blackford Quentin S.Director, President, CEO
Sell $3.5M of disclosed value in iRhythm Technologies, Inc. $IRTC.
Sell
Tabuteau HerriotDirector, CEO, 10% Owner
Sell $6.0M of disclosed value in Axsome Therapeutics, Inc. $AXSM.
Sell
Heron Patrick JDirector
Buy $9.0M of disclosed value in Mirum Pharmaceuticals, Inc. $MIRM.
Buy
Kooij Louise FrederikaCAO
Sell $2.4M of disclosed value in NewAmsterdam Pharma Company N.V. $NAMS.
Sell
Patel AnishCOO
Sell $1.3M of disclosed value in Enliven Therapeutics, Inc. $ELVN.
Sell
Somaiya Mayur IanCFO
Sell $3.2M of disclosed value in NewAmsterdam Pharma Company N.V. $NAMS.
Sell
Lyssikatos Joseph PCSO
Sell $3.5M of disclosed value in Enliven Therapeutics, Inc. $ELVN.
Sell
Bernstein HaroldPresident, R, D, CMO
Sell $1.0M of disclosed value in Maze Therapeutics, Inc. $MAZE.
Sell
Lilly Endowment Inc10% Owner
Sell $322.4M of disclosed value in Eli Lilly and Company Common Stock $LLY.
Sell
Opaleye Management Inc.10% Owner
Sell $1.1M of disclosed value in Harrow Health, Inc. $HROW.
Sell
Sohn Catherine A.Director
Sell $1.1M of disclosed value in Maze Therapeutics, Inc. $MAZE.
Sell
Tabuteau HerriotDirector, CEO, 10% Owner
Sell $23.9M of disclosed value in Axsome Therapeutics, Inc. $AXSM.
Sell
Chao XingjuanDirector, President, CEO
Sell $1.6M of disclosed value in CeriBell, Inc. $CBLL.
Sell
Burroughs Amy L.Director, CEO
Sell $2.7M of disclosed value in Terns Pharmaceuticals, Inc. $TERN.
Sell
Lilly Endowment Inc10% Owner
Sell $1.5M of disclosed value in Eli Lilly and Company Common Stock $LLY.
Sell
Rodman David MalcomCMO
Sell $9.3M of disclosed value in Mineralys Therapeutics, Inc. $MLYS.
Sell
Lian BrianDirector, President, CEO
Sell $7.5M of disclosed value in Viking Therapeutics, Inc. $VKTX.
Sell
Saad Mark EDirector
Sell $5.2M of disclosed value in Axsome Therapeutics, Inc. $AXSM.
Sell
Zante GregCFO
Sell $1.0M of disclosed value in Viking Therapeutics, Inc. $VKTX.
Sell
Dandekar AtulCSBO
Sell $2.9M of disclosed value in Maze Therapeutics, Inc. $MAZE.
Sell
Mancini MariannaCOO
Sell $1.0M of disclosed value in Viking Therapeutics, Inc. $VKTX.
Sell
Bernstein HaroldPresident, R, D, CMO
Sell $1.8M of disclosed value in Maze Therapeutics, Inc. $MAZE.
Sell
Lilly Endowment Inc10% Owner
Sell $3.9M of disclosed value in Eli Lilly and Company Common Stock $LLY.
Sell
Kooij Louise FrederikaCAO
Sell $5.2M of disclosed value in NewAmsterdam Pharma Company N.V. $NAMS.
Sell
Lilly Endowment Inc10% Owner
Sell $2.9M of disclosed value in Eli Lilly and Company Common Stock $LLY.
Sell
Showing 61-90 of 226